PGA 76 (New York City, 9-13 December 2022)

New York City, USA (9-13 December, 2022) – The STIMPOD NMS450X will be exhibited at PGA76. You can learn more about the STIMPOD NMS450X here. Download the full scientific programme here.  Visit Bell Medical at Booth 115 and see the STIMPOD NMS450X Objective NMT Monitor in action! The 1st handheld multi-sensor NMT monitor, with both…

FDA approves EMG for STIMPOD NMS450X

Pretoria, South Africa – Xavant Technology announced that the FDA has approved the expansion of the sensor technology in its STIMPOD range of Quantitative NMT Monitors to include electromyography (EMG). To date, Xavant’s range of Quantitative Neuromuscular Monitoring (NMT) monitors have been equipped with acceleromyography (AMG) sensors only – until now. The U.S Food and…